Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom
The British Journal of Psychiatry – February 01, 1971
Source: OpenAlex
Summary
Mescaline and LSD have been linked to serious adverse effects, yet a comprehensive survey of psychiatrists reveals a different perspective. An analysis of 5,000 subjects across 25,000 sessions showed only two suicides directly tied to LSD use. Psychotic reactions occurred at a rate of 0.8 per 1,000 experimental subjects and 1.8 per 1,000 patients. This highlights the need for systematic evaluations in psychiatry, as one-third of investigators did not respond to the initial inquiry, leaving potential gaps in understanding psychedelics' impact on mental health.
Abstract
It is well recognized that LSD (lysergide) can give serious adverse reactions, including suicide and prolonged psychosis; Smart and Bateman (1967) have reviewed the subject thoroughly. However, examples reported refer largely to cases where the LSD was self-administered. Medical case reports usually cover small case numbers, and publication may be determined by high adverse reaction rates. There has been no methodical survey of the pooled experience of psychiatrists since Cohen's study in 1960. This reported 44 replies sent out to 62 American investigators who had published papers or whose work was known to the author. Replies covered 5,000 subjects with 25,000 LSD or mescaline sessions. In this series, there were only two suicides that Cohen regarded as directly related to the LSD, and there were psychotic reactions (lasting more than 48 hours) at a rate of 0·8 per 1,000 experimental subjects and 1·8 per 1000 patients. It is unfortunate that one-third of the investigators failed to reply to Cohen's questionnaire.